MedPath

Tiespectus

Generic Name
Tiespectus

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Phase 1
Recruiting
Conditions
Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
BRVO - Branch Retinal Vein Occlusion
Interventions
First Posted Date
2024-10-29
Last Posted Date
2025-05-20
Lead Sponsor
EyeBiotech Ltd.
Target Recruit Count
92
Registration Number
NCT06664502
Locations
🇺🇸

Lemont, IL, Lemont, Illinois, United States

🇺🇸

Asheville, NC, Asheville, North Carolina, United States

🇺🇸

Wake Forest, NC, Wake Forest, North Carolina, United States

and more 24 locations
© Copyright 2025. All Rights Reserved by MedPath